By means of its function as both an ARB and a partial agonist for PPAR-γ, telmisartan provides numerous beneficial effects in ameliorating hyperglycemia and related complications in T2DM (Nagel et al., 2006; Goyal et al., 2008; Makino et al., 2008; Yamana et al., 2008; Hasegawa et al., 2009; Saitoh et al., 2009; Perl et al., 2010; Li et al., 2012). The gene discussed is PPARG; the disease is Hyperglycemia.